×
A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors PDF
$ 40.00
A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors PDF quantity
$ 40.00
×
Obstructive Sleep Apnea as a Complication of Bipolar Disorder and Its Treatment: A Review and Approach to Management PDF
$ 40.00
Obstructive Sleep Apnea as a Complication of Bipolar Disorder and Its Treatment: A Review and Approach to Management PDF quantity
$ 40.00
×
Are Depressed Outpatients With and Without a Family History of Substance Use Disorder Different? A Baseline Analysis of the STAR*D Cohort PDF
$ 40.00
Are Depressed Outpatients With and Without a Family History of Substance Use Disorder Different? A Baseline Analysis of the STAR*D Cohort PDF quantity
$ 40.00
×
Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine PDF
$ 40.00
Early Improvement as a Predictor of Treatment Response in Patients With Obsessive-Compulsive Disorder: A 12-Week Randomized Trial of Sertraline and Fluvoxamine PDF quantity
$ 40.00
×
Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis PDF
$ 40.00
Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
